Significant gaps remain in our understanding of Covid-19, and in many ways the coming period is going to be one of trial and error for nations. In particular, the asymptomatic nature of the virus in its early phase means that there is always a risk of unknown transmission. Governments will need effective trigger mechanisms – using novel data sources – and agile and responsive systems that enable them to act quickly if the reproduction number creeps up. Individuals may also want to take on greater responsibility for their health and disease detection, given the near universal failure of countries to price in risk and prepare for a pandemic, despite numerous warnings. With the power to both aggregate data and empower individuals, wearables could form part of a solution.
Delta tricks human cells into making way more copies of itself compared to previous variants. One study revealed that the viral load (number of viral copies) is 1,000 times higher for delta compared to the original SARS-CoV-2 strain. Viral load plays a big role in whether or not a person gets sick: if a person is exposed to higher levels of the virus, they are more likely to become infected.
You’ve probably heard a lot about vaccine passports this year: what they are, who’s making them and where you may be able to travel with one. That’s because a COVID-19 vaccine will be a new entry requirement for some destinations and travel providers, while others will use proof of vaccination to allow travelers to skip COVID-19 tests and mandatory quarantines.Because vaccine passports will streamline the travel experience, they’re being seen as a crucial component of restarting the industry after the pandemic. But which countries are using (or plan to use) digital vaccine passports? And which countries aren’t?
As in other sectors, digital marketing can help healthcare players reach a much larger audience, create awareness to drive their cause and attract patients by leveraging digital channels like Facebook, Google and other digital platforms. Digital-marketing channels and tools became critical with the onset of the Covid-19 pandemic as clinicians were faced with a reduced ability to interact with patients directly at the clinic.
Their service offerings currently cover menopause, pregnancy, fertility and early parenthood. Peppy offers employees a secure online environment that not only gives users direct access to expert medical practitioners and tailored care but also provides an online community of users experiencing similar life changes. The app functions include instant messaging, group chats, video consultations, relevant articles, programmes and events.
There’s currently a lot of buzz around regulations for digital health, particularly in Europe with the EU Medical Device Regulations (MDR) which went into effect May 26 after a one year delay due to the Covid-19 pandemic. Digital health thought leader Mark Tarby, who serves as BrightInsight’s vice president of regulatory and quality management systems, shared his take on what the new regulations will mean for connected devices, Software as a Medical Device (SaMD), and the go-to market strategies for the companies behind them.
The combined company will look to create new patient engagement programs looking to balance in-person and digital care, Amwell said, focusing in the areas of virtual care automation and patient companionship in its longitudinal care, behavioral health and other specialty and chronic care segments.
Truepill’s Virtual Pharmacy platform works behind the scenes to help payers, PBMs and health systems alike create customized, digital storefronts for prescriptions and OTC products, ultimately lowering costs and modernizing the shopping experience. Furthermore, the new offering provides the opportunity to improve specific use cases for OTC benefit utilization by creating a simple destination for patients to redeem their benefits.
The change for HICAPS (Health Industry Claims and Payments Service) simplifies the claims process for Australian clients. Members of Medibank, Bupa, nib, and GU Health can now download their digital membership card from their health fund app, and add it to Apple Wallet. Rather than swiping a plastic card, users will instead be able to tap their iPhone or Apple Watch on any HICAPS terminal to make a claim. Real-time notifications will be provided to the user, provided via their health fund's app.
The health records will also show a physician ID of the treating doctor and facility ID of the healthcare facility visited. Having such an ID will allow patients to trace their medical records, maintain them on mobile devices and access them during emergencies.
The three-year-old company targets organisations who want to offer support to employees facing life events like menopause, pregnancy, fertility and early parenthood, offering a range of digital tools to provide support to people and connect them with expert practitioners. Services include instant messaging, group chat, video consultations, live events, evidence-based articles, videos and programmes, and corporate client s include major lawfirms, banks, retailers and public sector employers, including some NHS trusts.
The mWell launch signals the opening of this new digital health ecosystem. Currently, in partnership with CareSpan, Philcare, and Keralty Clinic, a whole gamut of doctors and health practitioners have joined the mWell roster comprising of general practitioners and specialty doctors to enable much-needed access to health professionals during this pandemic. Doctors are able to easily manage digital appointments, keep patients’ confidential medical records, and issue e-prescriptions. And with the partnership of Medicard, users can book COVID-19 testing services.
The accelerator, created by Amazon Web Services, will pick 10 healthcare startups in the U.S. using cloud-based services. To start, it will focus on solutions like remote patient monitoring, voice technology, analytics, patient engagement, and virtual care.
The digital health passport will initially focus on making sure passengers meet their testing requirements for the journey. In the future, the plan is to integrate vaccination credentials before the end of the summer. This latter feature will be more helpful in destinations that open up or have already opened up for vaccinated travelers.
Founded in 2013, the company got its start as a symptom-triage checker, but has quickly expanded. The company has expanded into hybrid care with its NHS-backed service GP at Hand, which allows patients in the U.K. to sign up for the service in lieu of registering with their local general practitioner. The service includes digital triage, online video visits and in-person care centers.
PharmStars is helping to bridge the “pharma-startup gap,” a disconnect between pharma and startups which often arises from differences in culture, communication, and timing. Digital health has the potential to transform the pharmaceutical industry and patient experiences. Pharma continues to have high unmet needs for innovative “beyond the molecule” solutions. Startups offer an untapped wealth of these potential solutions. Yet digital health startups and pharma have historically found it challenging to create successful partnerships.
The study found that 98.1% of participants had not used digital health services prior to the pandemic. Although 52.2% of participants felt these services could help to reduce non-essential contact, 77.8% were uncomfortable with artificial intelligence software interpreting their medical results and providing automatic advice.
Just weeks after its debut, the PharmStars digital health accelerator nabbed its first pharma members—Boehringer Ingelheim, Eli Lilly and Takeda. The new matchmaking company is the first of its kind to focus specifically on connecting drugmakers to digital health startups.Founder and CEO Naomi Fried decided to launch the company after noticing a disconnect between pharma companies searching for digital health solutions and the entrepreneurial tech startups that were coming up with new ideas.
La situation sanitaire actuelle et le débat autour de la vaccination démontre la nécessité des citoyens/des patients d’être de plus en plus acteurs de leur santé et renforce aussi l’utilisation d’outils […]
Selon 88 % des sondés, l’administration numérique de médicaments est extrêmement ou très importante. Un tiers des entreprises pharmaceutiques interrogées possèdent une ou plusieurs thérapies numériques sur l
Cognizant and Phillips announced a strategic collaboration to develop digital health solutions intended to improve patient care and accelerate the clinical trials process by increasing connectivity across patients, providers and clinical researchers. The strategic alliance brings together Philips HealthSuite, a cloud-based platform and Cognizant’s digital engineering expertise to deliver and maintain leading-edge digital health solutions at scale, providing advanced connectivity and using big data to create actionable insights.
myOp is an all-in-one solution supporting patients and clinicians from the decision-to-operate to a full, speedy recovery. It delivers a variety of ‘prehabilitation’ interventions that have been shown to reduce complication rates by up to 50%. my mhealth has selected the most effective, evidence-based tools, combined with proven behavioural change techniques to deliver tailored care to patients.
After working to make its continuous glucose monitoring systems compatible with the major players in the diabetes device industry, Dexcom is opening its doors much wider. With an FDA blessing for Dexcom’s new web-based APIs, the company can invite digital health companies to feed its CGM data into their own health apps and devices—potentially expanding the different ways people with diabetes can share and use their blood sugar stats.
IoT systems were regarded as offering potentially helpful functionality in mediating the action plans developed with a trusted clinician, but technologically adept participants were not yet ready to trust artificial intelligence to generate novel advice. Research is needed to ensure that technological capability does not outstrip the trust of the individuals using it.
The digital health startup received FDA clearance for its carbon monoxide sensor to be used for smoking cessation without oversight from a healthcare provider. The expanded indication came after Carrot submitted the results of a single-arm study claiming its device increased people’s motivation to quit smoking.
Amazon Web Services wants to help incubate early-stage digital health companies that can collaborate with the tech giant's healthcare customers and partners. Amazon's cloud division launched a healthcare accelerator to boost startups' growth in cloud technologies and enable early-stage companies to tap into AWS' technical and commercial expertise.The program will focus on technologies such as remote patient monitoring, data analytics, patient engagement, voice technology and virtual care, according to a blog post from Sandy Carter, vice president of worldwide public sector partners and programs at AWS.
The health care industry is starting to adopt digital twins to improve personalized medicine, health care organization performance, and new medicines and devices. Although simulations have been around for some time, today’s medical digital twins represent an important new take. These digital twins can create useful models based on information from wearable devices, omics, and patient records to connect the dots across processes that span patients, doctors, and health care organizations, as well as drug and device manufacturers.
The most challenging part of this research was the development of the strain sensor to measure the intraocular pressure. Very little strain is caused by the change in the intraocular pressure, so, even though the strain sensor had high sensitivity, it was very difficult to measure the change in the intraocular pressure. To overcome this problem, we used a rigid-soft hybrid substrate and a highly-doped Si nanomembrane-based strain sensor that had serpentine geometry.
“The current system for diagnosing depression has quite a few flaws throughout the process,” says Molimpakis. “This has nothing to do with the clinicians themselves, it’s really to do with the tools that they have.”
A study involving virtual rather than real patients was as effective as traditional clinical trials in evaluating a medical device used to treat brain aneurysms, according to new research. The findings are proof of concept for what are called in-silico trials, where instead of recruiting people to a real-life clinical trial, researchers build digital simulations of patient groups, loosely akin to the way virtual populations are built in various computer games.